Immunic Inc. (IMUX) Tops Q3 EPS by 2c

Immunic Inc. (NASDAQ: IMUX) reported Q3 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
• JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
• Morgan Stanley Starts Target Hospitality (TH) at Overweight